February 4, 2021
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) released its FY20 annual report today. The report is available online at https://www.hjf.org/ar-20 and downloadable in print format.
Since 1983, HJF has been a vital link—the “connective tissue”—between military medical research partners and private industry and academic institutions.
The COVID-19 global pandemic severely impacted nearly every aspect of daily life. HJF joined military partners and medical researchers around the world to work towards discovery of therapeutics, vaccines, and treatments for this novel coronavirus. With significant experience studying HIV, Ebola, anthrax, malaria, SARS-CoV, MERS-CoV, H1N1 and Zika, HJF has the knowledge and skills necessary to effectively support infectious disease research in scalable fashion. The FY20 Annual Report highlights the many efforts HJF supported in the battle against COVID-19.
“COVID-19 dominated the news in fiscal year 2020, and, as a result, our FY20 annual report has an entire section dedicated to highlighting HJF’s efforts in response to COVID-19,” said HJF President and CEO Dr. Joseph Caravalho. “HJF’s unique position as a partner in military medical research enabled us to support the COVID-19 efforts on multiple fronts. Together with our military partners, we developed innovative treatments, diagnostics, and therapeutics in record time. I am immensely proud of the HJF team for everything we have accomplished together in fiscal year 2020.”
HJF’s FY20 annual report highlights the work of more than 2,700 teammates who worked to advance military medicine. More than 180 new research awards were received in FY20 and 1,295 research protocols were executed.
“Our year was not confined only to COVID-19 research,” said Dr. Caravalho. “HJF also supported hundreds of non-COVID research initiatives to benefit our nation’s warfighters, their families, and civilians alike.”
Read about HJF’s fiscal year at https://www.hjf.org/ar-20.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) is a global nonprofit that administers more than $500 million in medical research funds annually. For more than 35 years, HJF has partnered with researchers and clinicians to provide bench to bedside to battlefield research support. More than 3,000 HJF teammates ensure HJF is a trusted and responsive partner by providing scientific, administrative and program operations services to researchers in the military, academia, and private industry. For more information, visit hjf.org.